Sun Pharmaceutical announces USFDA approval for Nicardipine Injection

Nov. 18 | Sun Pharmaceutical Industries, an international, integrated, specialty pharmaceutical company, announced that the USFDA has granted its subsidiary an approval for its application for Nicardipine Hydrochloride Injections. These Nicardipine Hydrochloride...

Wockhardt launches Nicardipine injections in USA

Nov. 18 | Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing the 25mg/10 ml injection of Nicardipine HCI, which is used for short-term management of hypertension...

Sun Pharmaceutical gets USFDA approval for generic Gleevec tablets

Nov. 17 | Sun Pharmaceutical, an international, integrated, specialty pharmaceutical company, announced that the USFDA has granted tentative approval to an Abbreviated New Drug Application (ANDA) for generic Gleevec, imatinib mesylate tablets. These imatinib mesylate...

Aurobindo Pharma receives final approval for Cefotaxime Injection USP

Nov. 9 | Aurobindo Pharma Limited has received final approvals from the US Food & Drug Administration (USFDA) for 2 ANDAs namely Cefotaxime for Injection USP 500mg, 1g, 2g and Cefotaxime for Injection USP 10g pharmacy bulk pack. Cefotaxime for Injection is...

Aurobindo Pharma receives final approval for Lamotrigine Tablets from USFDA

Nov. 6 | Aurobindo Pharma, one of the largest API manufacturers in Asia, has received the final approval for Lamotrigine Tablets     (Chewable, Dispersible) 5mg and 25mg from the US Food & Drug Administration (USFDA). Lamotrigine Tablets 5mg and 25mg is...